Early detection of cancer not only holds promise for its cure but also reduces the cost of treatment. Recently, certain biomarkers associated with tumor growth and development have been utilized for early diagnosis of cancer. Detection of these biomarkers in biological fluid using molecular techniques...
Background : Obesity is linked to the development of postmenopausal breast cancer, and some studies indicate obesity predicts a worse prognosis for premenopausal women who develop the disease. It was our hypothesis that proteins associated with breast cancer would be associated with body mass index (...
Lung cancer is the leading cause of death for neoplasm. Lung cancer mortality is frequently associated with late diagnosis, therefore an early diagnosis is... R Gasparri,R Romano,G Sedda,... - 《Journal of Breath Research》 被引量: 7发表: 2017年 Detection of Lung Cancer with Breath Biomar...
期刊简介: Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathologi...
Gastric cancer (GC) is one of the most common types of malignancy. Its potential molecular mechanism has not been clarified. In this study, we aimed to explore potential biomarkers and prognosis-related hub genes associated with GC. The gene chip dataset GSE79973 was downloaded from the GEO da...
Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion...
DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism An analysis of three multi-cancer cohorts shows that the detection of ctDNA using liquid biopsies has the potential to improve the risk prediction of cancer-associated venous thromboembolism. Justin Jee , A. Rose Brannon ...
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy With recent approvals for multiple therapeutic antibodies that block cytotoxic T lymphocyte associated antigen 4 (CTLA4) and programmed cell death protein 1 (PD1) in melanoma, non-small-cell lung cancer and kidney cancer...
cancer patients treated with anti-PD-1 mAbs have been reported to have rapid cancer progression, called highly progressive disease (HPD). HPD development is associated with enhanced suppressive activity of tumor-infiltrating PD-1 + Treg cells due to PD-1 blockade [46]. Therefore, targeting ...
Journal Title:Cancer Biomarkers Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral ...